Study objective: To assess differences in gene expression in cholinergic basal forebrain cells between sleeping and sleep-deprived mice sacrificed at the same time of day. Methods: Tg(ChAT-eGFP)86Gsat mice expressing enhanced green fluorescent protein (eGFP) under control of the choline acetyltransferase (Chat) promoter were utilized to guide laser capture of cholinergic cells in basal forebrain. Messenger RNA expression levels in these cells were profiled using microarrays. Gene expression in eGFP(+) neurons was compared (1) to that in eGFP(−) neurons and to adjacent white matter, (2) between 7:00 am (lights on) and 7:00 pm (lights off), (3) between sleep-deprived and sleeping animals at 0, 3, 6, and 9 hours from lights on. Results: There was a marked enrichment of ChAT and other markers of cholinergic neurons in eGFP(+) cells. Comparison of gene expression in these eGFP(+) neurons between 7:00 am and 7:00 pm revealed expected differences in the expression of clock genes (Arntl2, Per1, Per2, Dbp, Nr1d1) as well as mGluR3. Comparison of expression between spontaneous sleep and sleep-deprived groups sacrificed at the same time of day revealed a number of transcripts (n = 55) that had higher expression in sleep deprivation compared to sleep. Genes upregulated in sleep deprivation predominantly were from the protein folding pathway (25 transcripts, including chaperones). Among 42 transcripts upregulated in sleep was the coldinducible RNA-binding protein.
INTRODUCTION
Elucidating the molecular changes that occur in neurons with sleep compared to wake is required to understand the underlying processes regulating these behavioral states. Previous transcriptional profiling studies using microarrays have examined changes in gene expression during sleep and wake and following sleep deprivation using samples from different brain regions that contained multiple cell types: for review, see. 1 These studies examined cortex and cerebellum in rat 2 ; telencephalon in birds 3 ; and cortex and hypothalamus in mice, 4 Drosophila head, and brain samples. 5, 6 Results from these microarray studies have led to the hypothesis that sleep plays an important role in synaptic homeostasis (for review, see ref. 7 ). Genes involved in synaptic plasticity including Bdnf, Arc, and Homer 1a are upregulated during wakefulness and downregulated during sleep. 2 Genes involved in protein synthesis, heme synthesis, and cholesterol synthesis are also upregulated during sleep, 4 suggesting that sleep facilitates macromolecule biosynthesis. 4 Moreover, in all species studied to date, extended wakefulness leads to upregulation of molecular chaperones such as BiP. [2] [3] [4] 8, 9 This has led to the hypothesis that extended wakefulness leads to endoplasmic reticulum (ER) stress and activation of the unfolded protein response (for review, see 10 ).
While these studies have made important contributions to the understanding of transcriptional changes during sleep-wake and sleep deprivation, they were carried out using relatively large heterogeneous areas of dissected brain regions. Given the resulting cellular heterogeneity, it is therefore unclear what cell types are contributing to the observed changes in gene expression. We know from studies using translating ribosome purification technology that there are changes in the transcriptome between sleeping, wake, and sleep-deprived animals in other cell types in brain, specifically oligodendrocytes 11 and astrocytes. 12 The basal forebrain has long been identified as a key region responsible for controlling sleep and wakefulness with contributions arising primarily from cholinergic, glutamatergic, and GABAergic neurons enriched in this region. [13] [14] [15] Recent approaches applying optogenetics and microdialysis have identified a variety of distinct roles for each of these neuronal populations in sleep-wake regulation, with a clear demonstration of the importance of cholinergic neurons in the basal forebrain for modulating sleep-wake transitions, homeostasis, vigilance, and electroencephalogram (EEG) Delta activity. 14, [16] [17] [18] [19] [20] Studies have examined the role of neurotransmitter systems in the regulation of these neurons 21 and the effect of this neuronal population on other cellular groups. 14 
Significance Statement
Sleep is critically important for health, and sleep disorders have significant societal and medical consequences. Despite the importance of sleep across species, much remains to be understood regarding the basic molecular mechanisms governing sleep and wake and the physiological responses to sleep deprivation at the level of discrete sleep-wake circuits. This work compared specific transcriptional responses in cholinergic basal forebrain neurons between normally sleeping and sleep-deprived mice, for the first time examining the distinct role of these neurons in the transcriptomic response to sleep deprivation. We identified changes in a number of circadian genes in these neurons at different times of day and intriguingly observed increases in expression of genes responsible for protein production and stabilization in response to sleep deprivation.
Despite only representing ~5% of the total cell population of the basal forebrain, 22 cholinergic neurons play a central role in the control of sleep and wake, with much remaining unknown about the underlying transcriptional responsiveness of these neurons across the normal sleep-wake period and in response to sleep deprivation. Conducting studies in mice expressing enhanced green fluorescent protein (eGFP) driven by different neuronal promoters 23 opens the opportunity to isolate and study the molecular makeup of specific neuronal subtypes. We used this approach to examine differences in gene expression, specifically within cholinergic cells in basal forebrain between sleep and extended wakefulness. These cholinergic neurons are highly active during wakefulness while their firing declines during non-rapid eye movement (NREM) sleep 24, 25 and are part of the major arousal system driven by glutamatergic cells in midbrain and within the basal forebrain itself. 14, 16, 26 A fuller understanding of the intracellular signaling and responses to sleep deprivation specifically within cholinergic basal forebrain neurons could provide insight into how this small, but significant population of cells enables cortical arousal and regulates sleep and wakefulness.
We utilized laser microcapture (LCM) to isolate eGFP-expressing cells in the basal forebrain, where eGFP was driven by the cholinergic promoter. Using Affymetrix microarrays, the expression profiles of the ChAT-eGFP(+) samples were compared to eGFP(−) neurons from adjacent regions on the same brain sections as well as white matter to evaluate the enrichment of RNA from ChAT-eGFP(+) cells. Second, to validate that we could distinguish differential expression within ChATeGFP(+) cells, we compared differences in gene expression between lights on (7 am) and lights off (7 pm). Finally, we compared gene expression in ChAT-eGFP(+) samples between mice allowed to sleep for different durations across the inactive (lights on) period (0, 3, 6, and 9 hours) with mice kept awake by gentle handling and sacrificed at the same time of day. Our results indicate that the most predominant transcriptional changes in these neurons between sleep and wake are in protein-folding genes.
MATERIALS AND METHODS

Animals
The Tg(ChAT-eGFP)86Gsat mice expressing eGFP under the control of choline acetyltransferase (Chat) gene promoter were developed by Heintz at the Rockefeller University (NY; for details see 23 ) . All experiments were performed in accordance to guidelines and were approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania.
Three independent microarray studies were performed. First, we compared expression profiles in ChAT-eGFP(+) cells to that in eGFP(−) and to adjacent white matter (n = 4-5 in each group, male, aged 12 weeks). Mice for these studies were sacrificed at the same time of day (3 hours after lights on). Second, we compared differences in expression in ChAT-eGFP(+) cells between 7 am (lights on) and 7 pm (lights off; n = 5 in each group). Finally, we compared gene expression between sleeping and sleep-deprived animals sacrificed at the same time of day. There were total of 7 groups for this experiment (all lights on) sacrificed at 0, 3, 6, and 9 hours of sleep deprivation from lights on with time matching spontaneous sleep controls (3, 6 , and 9 hours). There were 4-5 animals in each of the 7 groups. All animals were individually housed with 7 am/7 pm lights on/off and food and water ad libitum. Sleep deprivation was conducted by gentle handling.
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Behavioral Assessment Behavioral assessments were conducted by measuring electronic beam crossing. In previous studies in both young 28 and old 29 C57BL/6 mice, we have shown that defining sleep as any period of inactivity of 40 seconds or more gives accurate estimates of sleep and wake. 28 As Tg(ChAT-eGFP)86Gsat mice are on a Swiss-Webster background, we assessed the validity of this algorithm in this genotype by recording, in 8 Swiss-Webster male mice of 3 months of age, wake, and substages of sleep by EEG/electromyography (EMG) recordings using techniques described previously from our laboratory. 28 Simultaneous recordings of activity by crossing electronic beams were performed. To assess the validity of an algorithm to estimate sleep based on activity, we calculated the total error between estimates of total sleep in 24 hours from gold standard EEG/EMG recordings and from electronic beam split data. We computed error 2 with different definitions of durations of inactivity to define sleep, that is, from 10 to 120 seconds in intervals of 10 seconds (see Figure 1A ). While defining sleep as 40 seconds or more of inactivity gave a reasonable agreement, using 50 seconds as the definition resulted in the lowest magnitude of error in this genotype (see Figure  1A) . Thus, in all studies, we used a definition of sleep as >50 seconds or more of continuous inactivity. There was excellent agreement between sleep defined by inactivity and that by EEG/EMG recording in the same mice (see Figure 1B) . We assessed the degree of agreement of sleep amounts between estimates based on activity/inactivity with that for EEG/EMG using the Bland-Altman approach (see Results and Figure 2 ). For subsequent studies of spontaneous sleep groups, animals were only sacrificed if the 3 hours before sacrifice they had >75% of time being identified as sleep. Animals not reaching this threshold were studied and sacrificed on subsequent days if they met this threshold.
Preparation of Mouse Brain Slices
After cervical dislocation, the brains were quickly removed and rinsed in nuclease-free 1× phosphate-buffered saline (PBS). Approximately 3-4 mm coronal slices containing basal forebrain (from Bregma +1.00mm to Bregma −2.00mm) were fixed in ice-cold 4% paraformaldehyde (pH 7.4) for 5 minutes, rinsed twice with PBS, frozen in cryo-embedding medium OCT (Tissue-Tek), and stored at −80ºC until all samples were collected for sectioning; 10-μm frozen sections were generated uninterruptedly. Slices were captured on saline-coated microscope slides, four to six slices per slide, and stored at −80°C until use in LCM. Prior to LCM, slices were rapidly dehydrated following the protocol: 75% EtOH ( 
Immunohistochemistry
Immunostaining for choline acetyltransferase (ChAT) was performed with a modified protocol previously described by Saito et al. 30 Briefly, adult male Chat-eGFP mice, 6-8 weeks of age were deeply anesthetized with the mix of ketamine and xylazine (80 and 10 mg/kg body weight, respectively), perfused transcardially with PBS, followed by 4% paraformaldehyde, and post-fixed in 15% sucrose. Brains embedded in OCT were sectioned at a thickness of 15 microns and the imaging of the eGFP was performed with Nikon Eclipse Ti microscope prior to the ChAT immunostaining. The immunostaining for choline acetyltransferase followed the above-referenced protocol using the primary rabbit anti-ChAT antibody (ABCAM) and Alexa 488-conjugated anti-rabbit IgG (Molecular Probes). The eGFP imaging and ChAT immunostaining were overlaid to visualize the colocalization of eGFP and ChAT.
LCM and RNA Isolation
Using the Veritas LCM System (Molecular Devices), ChATeGFP(+) and ChAT-eGFP(−) cells from basal forebrain as well as the white matter were captured according to a published protocol following sectioning at 10 μm. 31 Each sample represented a collection of at least 150 cells.
For RNA purification, we used PicoPure® silica column purification kit (Applied Biosystems), including DNAse I treatment. PicoChip using the BioAnalyzer 2100 (Agilent Technologies, Inc.) and the NanoDrop™ fluorospectrometer (Thermo Scientific) using Ribogreen (Invitrogen) to assure total RNA quality and quantity.
Affymetrix mRNA Profiling and Data Pre-Processing RNA amplification and hybridization were performed as described previously. 31 Briefly, samples were amplified and labeled using a custom 2 cycle version of the Biotin MessageAmp II TM aRNA Amplification kits from Ambion. Total RNA of 1-5 ng were added to the initial reaction mix together with 250 ng of pBR322 (Invitrogen). Following the first round of in vitro transcription (IVT), the plasmid carrier was removed with a DNaseI treatment. The first round IVT products were purified using the Qiagen MinElute Kit (Qiagen). Input into the second round was normalized to the lowest yielding sample. Hybridization to custom mouse Affymetrix arrays containing 43 746 probe sets, labeling, and scanning were completed following the manufacturer's recommendations, and profiles were normalized using robust multiple array average (RMA) technique as described previously. 32 Custom arrays were designed to monitor additional genes and polyA sites than commercially available microarrays. Sample amplification, labeling, and microarray processing were performed by the Rosetta Inpharmatics Gene Expression Laboratory in Seattle, WA. The quality and reproducibility of gene expression data using this approach have been described previously. 31, 33, 34 The resulting profiles were further analyzed using MATLAB Statistics toolbox.
Gene Set Annotation
Pathway analyses were conducted using a compilation of GeneGo, GeneOntology, DAVID, KEGG, and Ingenuity gene sets. The significance of input gene set similarity was assessed by the exact Fisher's p values with Bonferroni correction for multiple testing (Expectation value or E-value). E values below 0.1 were accepted as significant.
Statistical Analyses
Assessment of behavior
To examine the agreement between EEG-based sleep and that calculated using the beam break method, we conducted a Bland-Altman analysis of estimated sleep. Specifically, for each time window, we calculated the animal-specific difference in sleep between the two methods (beam break values − EEG values) as well as the average of the two methods. Using these two metrics, agreement between the EEG and beam break methods was examined using linear mixed models accounting for repeated measures (i.e., 2-hour time windows) within each mouse by (1) testing whether there was a significant difference between the techniques overall, that is, if the average difference was different from zero, and (2) assessing whether there was an association between the EEG and beam break difference and mean value. To examine the likely spread of differences, we also calculated the Bland-Altman limits of agreement, equal to ±2 SD around the mean difference; the SD was calculated as the square root of total variability in the differences from the linear mixed model.
Analysis of gene expression data
Principal Component Analysis and hierarchical clustering with a bottom-up algorithm were used to identify potential outliers and expression signatures. One ChAT-eGFP(−) sample failed standard quality control metrics and was removed from analysis. We used analysis of variance (ANOVA) to identify differences between (1) ChAT-eGFP(−) and ChAT-eGFP(+) cells or the white matter (n = 4, 5, and 5 per group, respectively), and (2) between 7 am and 7pm in ChAT-eGFP(+) cells only (n = 5 per group). Two-way ANOVA was used to identify differential gene expression during the time course after 3, 6, and 9 hours of spontaneous sleep compared to sleep deprivation (n = 5 per group) having time, behavioral state (sleep/sleep deprivation) and interaction in the model. False discovery rate (FDR) was used for an additional assessment of significance and calculated using established methodology. 35 
RESULTS
Agreement Between Activity/Inactivity Defined Sleep and That From EEG/EMG Recording
The results of our mixed model-based Bland-Altman analysis comparing EEG and beam break calculated sleep are presented in Figure 2 . On average, the two techniques resulted in nearly identical estimates of sleep, with slightly more sleep estimated using beam breaks (mean [95% CI] difference = 1.61 [−3.85 to 7.07] minutes; p = .507). Limits of agreement ranged from −21.6 to 24.8 minutes, indicating that approximately 95% of the differences between the techniques are expected to be within 20-25 minutes. There was no significant association between the difference and average values from the two techniques (β [95% CI] = −0.06 (−0.17 to 0.04); p = .223], indicating no systematic bias in the differences. Thus, there is evidence of substantial agreement between the beam break method and EEG measured sleep.
LCM Yields Distinctive ChAT-eGFP mRNA Signatures in Rodent Basal Forebrain
All eGFP-labeled neurons were ChAT expressing (see Figure 3) . In Figure 3 , the top panel shows the neurons expressing eGFP, those that are ChAT positive by immunohistochemistry, and the merged image. In the bottom panel, a representative dissection and isolation of eGFP-positive cells is demonstrated.
Transcriptional profiling of basal forebrain ChAT-eGFP(+) neurons revealed distinct signatures compared to the white matter and adjacent ChAT-eGFP(−) cells. Mice used in these studies were all sacrificed at the same time of day (10 am). A total of 2671 transcripts were identified as differentially expressed between ChAT-eGFP(−) and white matter (T-test p < .01, set FDR < 6%, Figure 3 , top left). Of these transcripts, 573 had FDR < 5%. Notably, canonical oligodendrocyte and astrocyte mRNA biomarkers were expressed highest in white matter samples, 36 while canonical neuronal mRNA markers were enriched in the ChAT-eGFP(−) and ChATeGFP(+) samples compared to white matter ( Figure 4 , top right); 828 transcripts were different between ChAT-eGFP(−) and ChAT-eGFP(+)T-test p < 0.01 ( Figure 4A, bottom left) . Although no individual gene had FDR < 5%, mRNA markers of cholinergic neurons were consistently expressed higher in ChAT-eGFP(+) cells, while GABAergic markers were higher in ChAT-eGFP(−) cells ( Figure 4B, bottom right) . The ChAT transcript was the second most enriched of all transcripts in ChAT-eGFP(+) cells, namely, 11.8-fold higher in ChATeGFP(+) versus ChAT-eGFP(−) samples (Table 1) . ChAT enrichment was exceeded only by Ntrk1 (12.5-fold) which regulates ChAT expression in basal forebrain cholinergic neurons. The cholinergic markers Slc17a8, Ngfr, Slc18a3, and Slc5a7 were the next most enriched genes (Table 1) .
Together, these data demonstrate that isolation of ChATeGFP(+) cells successfully markedly enriches for mRNA from cholinergic neurons within the ChAT-eGFP(+) samples compared to adjacent neurons and white matter.
Different Transcript Expression in ChAT-eGFP(+) Neurons
Between Lights On (7 am) and Lights Off (7 pm) We found 590 transcripts differentially expressed in ChATeGFP(+) neurons between lights on (7 am) and lights off (7 pm) time points (t-test p < .01; Figure 5A ). While no individual transcripts had FDR < 5%, the known clock gene Arntl2 was downregulated at the end of the light phase (7 pm; light-dark transition), while Per1, Per2, Dbp, Nr1d1 were upregulated in accordance with the circadian expression database (http:// circadb.hogeneschlab.org/). These findings provide further validation of our approach.
We also observed significantly increased expression of metabotropic glutamate receptor Grm3 (mGluR3) at 7 am compared to 7 pm in ChAT-eGFP(+) samples (7am/7pm 1.86-fold, p < .01). This suggests that this receptor may have a role in sleep-wake control by modulating the activity of these neurons.
Time Course of Transcriptional Changes in Basal Forebrain Cholinergic Neurons in Sleep and Sleep Deprivation
Using ANOVA, we found 835 transcripts that had significant differences for time of day (ANOVA p < .01); however, none met the individual transcript FDR < 5% cut off. The sleep/sleep deprivation comparison identified 573 differentially expressed transcripts (ANOVA p < .01) with 10 transcripts meeting FDR < 5% criteria. Figure 6 shows p value distribution for each of the comparisons (time, behavioral state). One transcript was borderline significant for interaction of time and behavioral state (sleep/ sleep deprivation)-Mesdc2 (1.02-fold, FDR 0.05; LDLR chaperone MESD precursor assisting the folding of beta-propeller/EGF modules within the family of low-density lipoprotein receptors).
Of the 10 transcripts with FDR < 5% in the sleep deprivation/spontaneous sleep comparison, 7 were up-egulated in the sleep-deprived group and included Slc5a3 (1.7-fold, FDR 0.018, inositol transporter known to be involved in neuronal Figure 6B ).
Similarly, of the 96 transcripts with a cut-off (p < .001 between the sleep-deprived and sleeping groups; for full list, see Supplemental Table S1 ), 55 transcripts were upregulated ( Figure 7A ) and 41 downregulated ( Figure 7B ) during sleep deprivation. The hierarchical clustering of these 96 transcripts is shown in Figure 7A and B. Gene set annotation analysis indicated the 96 transcripts were most significantly enriched for genes involved with protein folding (25 transcripts, Bonferroni p = .002; for full list refer to Supplemental Table S2 ). The average change in expression of the 25 protein-folding transcripts was plotted with respect to time of day for both sleep-deprived Slc1a2, solute carrier family 1 (glial high affinity glutamate transporter), member 2; Neuron: Gabra1, gamma-aminobutyric acid type A receptor alpha1 subunit; Nefh, neurofilament, heavy polypeptide; Nefl, neurofilament, light polypeptide; Nefm, neurofilament, medium polypeptide; Oligodendrocyte: Gjc2, gap junction protein gamma 2; Mbp, myelin basic protein; Mog, myelin oligodendrocyte glycoprotein, Sox10; SRY-box 10; Cholinergic: Ache, acetylcholinesterase; Chat, choline acetyltrasferase; Slc18a3, solute carrier family 18 (vesicular acetylcholine transporter), member 3; Slc5a7, solute carrier family 5 (sodium/choline cotransporter), member 7; GABAergic: Gad1, glutamate decarboxylase 1; Gad2, glutamate decarboxylase 2, Slc32a1, solute carrier family 32 (GABA vesicular transporter), member 1; Slc6a1, solute carrier family 6 (neurotransmitter transporter), member 1; Slc6a11, solute carrier family 6 (neurotransmitter transporter), member 11. Abbreviations: eGFP, enhanced green fluorescent protein; ChAT, choline acetyltransferase. SLEEP, Vol. 40, No. 6, 2017 Differences in Gene Expression Between Sleep and Wake-Nikonova et al. and sleeping groups ( Figure 8 ). Their expression increased during sleep deprivation across the lights on period, while there expression declined during sleep over the same time period. Of these 25 transcripts, 4 had individual FDRs < 5%: Manf (Armet), Hspa5, Chordc1, and Hspb1 reported earlier (complete list can be seen in Supplemental Table S2 ).
DISCUSSION
The main molecular pathway affected by sleep and sleep deprivation in basal forebrain cholinergic cells was protein folding. A number of genes involved in this pathway, including molecular chaperones, increased expression during induced wakefulness and decreased expression during sleep. Behavioral state-associated changes in the expression of these genes has been shown in brain regions of many species such as Drosophila, 8 mice, 37 rats, 2,9 and birds. 3 These previous studies were performed using brain tissue homogenates, and the current study is the first to localize these transcriptional changes to neurons involved in sleep-wake control. Previous studies have shown that shortterm sleep deprivation in mice not only modulates the mRNA expression of unfolded protein response genes but also that posttranslational modifications in this pathway also occur (such as phosphorylation of PERK and eIF2α 10, 29, 37 ). Somewhat surprisingly, changes in expression of genes in this pathway occur not only in brain but also in peripheral organs. 38 As in brain, there is reduced expression of molecular chaperones in lung and heart during sleep and increased expression with extended wakefulness. The specific gene changes in the two peripheral organs are remarkably similar to the changes in brain reported here (see Figure 4 in 38 ). This suggests coordinated signaling of protein-folding genes between the brain and peripheral organs with changes in behavioral state, and there must be some signal from the brain that is related to behavioral state that coordinates these changes. This phenomena is not secondary to glucocorticoid signaling, since similar findings with sleep deprivation were observed in the brain of adrenalectomized mice in which glucocorticoid signaling was maintained constant. 39 It has been shown in C. elegans that brain can communicate protein-folding responses to the periphery. 40 Increasing the nervous system expression of a key component of this pathway, XBP-1, affected the unfolded protein response in distal nonneuronal cells. 40 This effect could be blocked by reducing release from small vesicles in neurons although the responsible neurotransmitter was not identified. 40 While the changes we observed are likely secondary to the effects of behavioral state, we do not know if they also might play a role in regulation of the state itself. There is some evidence from different species that this may be so. In C. elegans, induction of cellular stress induces a behavioral quiescent state in adult worms that has similarities to the natural sleeplike state-lethargus-that occurs during development. 41 The behavioral quiescence induced by cellular stress is mediated by the single ALA neuron. 41 There is evidence of distinct neuronal circuits for lethargus and sleep induced by stress. 42 In Drosophila, changes in expression of the key molecular chaperone, BiP/GR178, alters recovery sleep following sleep deprivation. 43 Also in Drosophila, administration of the chemical chaperone saline-4 phenlbutyrate (PBA) ameliorates age-related alteration in sleep. 44 But most importantly intracerebrovascular administration of salubrinal increases the amount of NREM sleep in rats. 45, 46 This drug affects one of the downstream targets of the unfolded protein response, that is, eIF2α. When this molecule is phosphorylated as part of the unfolded protein response, protein translation is inhibited. Salubrinal reduces the dephosphorylation of eIF2α, thereby inhibiting protein translation. c-fos expression in basal forebrain cholinergic cells with wakefulness is also reduced by salubrinal. 46 Thus, altering protein homeostasis in basal forebrain alters activity of cholinergic cells and in turn behavioral state, and therefore the changes we are describing in these neurons may also play a role in control of behavioral state.
Another gene that had a highly significant increase in expression with sleep compared to the sleep-deprived state was the cold-induced receptor-binding protein-Cirbp. 47 Expression of this gene is also increased in peripheral tissue with sleep. This was originally described by Maret et al. in mouse liver 48 but also is found in heart and lung, 38 while in humans the diurnal variation in its expression in circulating blood cells is markedly reduced when the timing of sleep is altered. 49 Expression of this gene is altered by temperature. Thus, its altered expression in sleep may be the result of the small reduction in temperature in brain that occurs during sleep. Expression of this gene is increased during hibernation in mammals 50 and frogs 51 and during aestivation in the African lungfish. 52 In tissue culture, rhythmic expression of this gene can be driven by induced temperature rhythms. 53 Expression of this gene shows diurnal variation in mouse liver. 54 This is not the result of local clock but by external temporal signals. 54 Cirbp interacts with a number of transcripts that is part of the circadian clock function, 53 and loss of Cirbp results in marked reduction in diurnal oscillation of clock gene expression. 53 In cells depleted of Cirbp, the abundance of CLOCK protein is markedly decreased. 53 That Cirbp regulates circadian gene expression has been suggested to be due to an effect on controlling alternative polyadenylation. 55 The precise role that increases in expression of the gene in cholinergic cells during sleep remains to be determined. It is of interest that expression of this gene is altered by sleep and yet downstream its level of expression directly affects clock mechanisms. This is another example of the interaction between sleep-related processes and that of the clock at a molecular level. Changes in clock gene expression with sleep deprivation vary at different times of the day. 56 Further investigation of the role of Cirbp in sleep-wake control and sleep homeostasis is needed.
Among the genes with altered expression between lights on (7 am) and lights off (7 pm) is the metabotropic glutamate receptor 3 (Grm3 or mGlur3). This type II metabotropic glutamate receptor is widely expressed both pre-and postsynaptically in neurons as well as astrocytes. 57 Glutamate is involved in sleepwake control, and its levels in cortex increase during wakefulness and REM sleep and decline during NREM sleep. 58, 59 The basal forebrain is an important part of glutamate-mediated arousal pathways. 60 There is a major arousal pathway from the parabrachial area that is glutaminergic and relays through the basal forebrain. 26 This pathway can be modulated by GABAergic cells in the parafacial zone to promote sleep. 60 Modulation of this arousal pathway by variations in mGlur3 levels in basal forebrain neurons could be an additional regulatory mechanism, as studies indicate that these receptors also play a role in sleep-wake control. LY379268, a selective mGlu2/3 receptor agonist, strongly suppresses REM sleep, while NREM delta power is increased; theta and high frequency spectra in the EEG are both decreased. 61 Conversely, the mGlu2/3 antagonist (LY341495) increases waking and enhances theta and gamma oscillations while decreasing delta power during sleep. 62, 63 Likewise, a negative allosteric modulator (RO4491533) produces a similar effect. 63 This action of the negative allosteric modulator is not found in mice in whom the mGlur2 receptor is knocked out. 63 That is, it seems that it is an effect mediated by mGlur2 not mGlur3 receptors. Although the effects of knockout of mGlur3 have been described, 64 there has been, to our knowledge, no study of sleep and wake in these mice.
Expression profiling studies, albeit using different technological approaches, have been used to assess genes changing expression with behavioral state in other cell types in brain. They indicate the specificity of the cellular responses. In astrocytes, 12 the largest category of genes changing expression between sleep and wake were related to the extracellular matrix and/or the cytoskeleton. Genes with increased expression in astrocytes during sleep were enriched for genes involved in cell development and proliferation as well as a gene coding for the MCT1 transporter involved in the astrocyte-neuron lactate shuttle. Wake genes included genes involved in elongation of astrocytic processes.
The pattern of change was different in oligodendrocytes.
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Genes increasing expression during sleep were overrepresented for phospholipid synthesis and myelination. One such gene-Opalin-increased expression during sleep in our samples. Genes increasing expression in oligodendrocytes during wakefulness included those involved in apoptosis and cellular stress response as well as in cell differentiation and development, for example, Creb1. We found in cholinergic basal forebrain neurons increases during sleep deprivation in genes in the CREB pathway and heat shock proteins, although the specific genes changing expression in the current study and that in oligodendrocytes were different. Our results are based on using LCM of neurons 65, 66 expressing eGFP under control of the ChAT promoter. 67 This is one way to obtain RNA from specific neuronal populations for expression profiling. One challenge with this approach is potential cross-contamination of mRNA obtained from adjacent glial cells. 68, 69 There was, however, in our study, substantial enrichment of mRNA from cholinergic cells with more than 11-fold enhancement of expression of Chat and other cholinergic markers from cholinergic cells compared to eGFP(−) neurons and adjacent white matter. Likewise, for white matter samples, there was marked enrichment of known astrocyte genes and those from oliogodendrocytes. Thus, while we cannot completely exclude the possibility that some component of the changes we are reporting come from astrocytes, it seems reasonable to conclude that the changes we describe are occurring primarily in basal forebrain ChAT+ cells. Another challenge is the quality and quantity of RNA obtained from LCM samples. It is possible for differences in RNA quality between regions and samples to produce artifactual measures of expression change. It was thus important to focus on sleep-related changes within the same region/cell populations and to assess a relatively large number of samples to obtain statistical significance. Our results are based on analysis of microarray data. We did not do additional validation studies. 
